Good news … Introducing the first drug to treat all types of cancer

13:23 28.11.2018(Update 13:29 28.11.2018) Copy link

The US Food and Drug Administration (FDA) has approved the world's first drug to treat any type of cancer, regardless of whether it originated or originated.

What makes it a "good news" for all cancer patients, is that the new drug is designed to be suitable for both adults and children.

Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease.

Scott Gottlieb, Commissioner of the US Commission "NBC News," said: "Ratification of this drug is an important step in the treatment of cancer because it treats at the source and treats the baseline of cancerous tumors, no matter what the place of origin in the human body ".

Gottlieb said the new drug will help cancer patients finally get the right treatment at the right time.

Viagracafe will help treat people with different cancerous tumors, but with common genetic mutations.

"Traditionally, the cancer was treated according to the source of the tumor, that is to say that it affected any part of the body, but now the treatment will be n?" anywhere in the body because you are treating it, "said David Hayman, president of the Center for Early Drug Development at the New York-based Memorandum Sloan Kettering Cancer Center. The original gene at the origin of the appearance of the tumor ".

The drug was tested on Anna Plaza and her daughter Rihanna last year after Anna had a cancerous tumor and her daughter Rihanna Burm was born with cancer on her arm.

Vitrakvi was administered to the newborn every day. Scientists were surprised to find that the tumor began to contract in just 3 days. In a few months, the tumor was completely eradicated and the doctors did not have to cut off the small child's arm.

The drug will be given to two bodies, the first in the form of tablets or capsules and the other in the form of children's drug syrup in particular.

But until now, the drug remains very expensive, the program costing more than $ 393,000 a year, while its cost per month will cost about $ 11,000.